Patent ID: 7229646
Filing Date: 2007-06-12
Classification: A23L,A23V,A61K,A61P

Abstract:
1. A method for treating lupus erythmatosus, which comprises administering to a patient in need of such treatment an effective amount of N,N-dimethylglycine and a PCE component which comprises freeze-dried and ground whole flesh and organs of the wherein the amount of N,N-dimethylglycine administered is from 1 to 500 mg/kg/day and the amount of the PCE component administered is from 1 to 500 mg/kg/day, and wherein the N,N-dimethylglycine and the PCE component are administered separately, or together as a composition, and wherein the N,N-dimethylglycine and the PCE component are each administered orally, or by intramuscular or intraperitoneal injection.